Home > Annual Financials > MOREPEN LABORATORIES

MOREPEN LABORATORIES Financial Statement Analysis
[BOM: 500288|NSE : MOREPENLAB]

The Revenues of MOREPEN LABORATORIES have increased by 7.17% YoY .
The Earnings Per Share (EPS) of MOREPEN LABORATORIES has increased by 14.36 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

MOREPEN LABORATORIES Last 5 Annual Financial Results
[BOM: 500288|NSE : MOREPENLAB]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹1,812 Cr₹1,690 Cr₹1,418 Cr₹1,547 Cr₹1,188 Cr
Expenses ₹1,638 Cr₹1,532 Cr₹1,338 Cr₹1,410 Cr₹1,070 Cr
Operating Profit (Excl OI) ₹174 Cr₹159 Cr₹80 Cr₹137 Cr₹119 Cr
Other Income ₹18 Cr₹14 Cr₹6.13 Cr₹20 Cr₹12 Cr
Interest ₹8.34 Cr₹3.71 Cr₹1.98 Cr₹2.43 Cr₹1.79 Cr
Depreciation ₹29 Cr₹33 Cr₹28 Cr₹28 Cr₹30 Cr
Profit Before Tax ₹155 Cr₹135 Cr₹56 Cr₹127 Cr₹99 Cr
Profit After Tax ₹118 Cr₹97 Cr₹39 Cr₹102 Cr₹97 Cr
Consolidated Net Profit ₹118 Cr₹96 Cr₹39 Cr₹102 Cr₹97 Cr
Earnings Per Share (Rs)₹2.15₹1.88₹0.76₹2.13₹2.16
PAT Margin (%)6.515.722.736.578.17
ROE(%)11.7812.085.9321.7929.20
ROCE(%)15.4816.828.4024.8627.13
Total Debt/Equity(x)0.070.030.030.030.04

Key Financials

Market Cap : ₹ 2,587.7 Cr
Revenue (TTM) : ₹ 1,781.6 Cr
Net Profit(TTM) : ₹ 93.3 Cr
EPS (TTM) : ₹ 1.7
P/E (TTM) : 27.7

Industry Peers & Returns1W1M1Y
MOREPEN LABORATORIES -5.2% -25.1% -21%
SUN PHARMACEUTICAL INDUSTRIES 2.6% -5.1% -6.4%
DIVIS LABORATORIES -0.5% -10.1% 21.8%
CIPLA 4.7% 4.8% -4.1%
TORRENT PHARMACEUTICALS 0.6% 5.2% 8.6%
DR REDDYS LABORATORIES 4.3% -0.7% -11.4%
MANKIND PHARMA -3% -7% 13%
ZYDUS LIFESCIENCES 4.6% 2.3% -23.5%
LUPIN 2.2% 1.9% -7.4%


MOREPEN LABORATORIES Revenues
[BOM: 500288|NSE : MOREPENLAB]

Y-o-Y

7.17 %

5 Yr CAGR

11.12 %

Years Revenues % Change
Mar2025 ₹1,812 Cr
7.17
Mar2024 ₹1,690 Cr
19.25
Mar2023 ₹1,418 Cr
-8.36
Mar2022 ₹1,547 Cr
30.20
Mar2021 ₹1,188 Cr -


MOREPEN LABORATORIES Operating Profit
[BOM: 500288|NSE : MOREPENLAB]

Y-o-Y

9.74 %

5 Yr CAGR

10.09 %

Years Operating Profit % Change
Mar2025 ₹174 Cr
9.74
Mar2024 ₹159 Cr
99.45
Mar2023 ₹80 Cr
-41.81
Mar2022 ₹137 Cr
15.32
Mar2021 ₹119 Cr -

Operating Margins
Y-o-Y

2.45 %

5 Yr CAGR

-0.94 %

Years Operating Margin% % Change
Mar2025 9.61%
2.45
Mar2024 9.38%
67.20
Mar2023 5.61%
-36.54
Mar2022 8.84%
-11.42
Mar2021 9.98% -

MOREPEN LABORATORIES Profit After Tax
[BOM: 500288|NSE : MOREPENLAB]

Y-o-Y

22.73 %

5 Yr CAGR

5.00 %

Years Profit After Tax % Change
Mar2025 ₹118 Cr
22.73
Mar2024 ₹96 Cr
148.64
Mar2023 ₹39 Cr
-61.97
Mar2022 ₹102 Cr
4.73
Mar2021 ₹97 Cr -

PAT Margins
Y-o-Y

13.81 %

5 Yr CAGR

-5.52 %

Years PAT Margin(%) % Change
Mar2025 6.51 %
13.81
Mar2024 5.72 %
109.52
Mar2023 2.73 %
-58.45
Mar2022 6.57 %
-19.58
Mar2021 8.17 % -

MOREPEN LABORATORIES Earnings Per Share (EPS)
[BOM: 500288|NSE : MOREPENLAB]

Y-o-Y

14.36 %

5 Yr CAGR

-0.12 %

Years EPS % Change
Mar2025 ₹2.15
14.36
Mar2024 ₹1.88
147.37
Mar2023 ₹0.76
-64.32
Mar2022 ₹2.13
-1.39
Mar2021 ₹2.16 -

MOREPEN LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500288|NSE : MOREPENLAB]

Y-o-Y

-7.97 %

5 Yr CAGR

-13.09 %

Years ROCE % Change
Mar2025 15.48%
-7.97
Mar2024 16.82%
100.24
Mar2023 8.4%
-66.21
Mar2022 24.86%
-8.37
Mar2021 27.13% -

MOREPEN LABORATORIES Share Price vs Sensex

Current Share Price : ₹47.2
Current MarketCap: ₹ 2,587.7 Cr
Updated EOD on :Aug 13,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-5.2%

-25.1%

-21%

SENSEX

-0%

-2.1%

1.1%

MOREPEN LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 2.7% -0.5% 8.6%
BSE SMALLCAP -0.3% -4.9% -2.8%
No NSE index found

You may also like the below Video Courses


FAQ about MOREPEN LABORATORIES Financials


How the annual revenues of MOREPEN LABORATORIES have changed ?

The Revenues of MOREPEN LABORATORIES have increased by 7.17% YoY .

How the Earnings per Share (EPS) of MOREPEN LABORATORIES have changed?

The Earnings Per Share (EPS) of MOREPEN LABORATORIES has increased by 14.36 % YoY .